Literature DB >> 11696454

Gp120-induced Bob/GPR15 activation: a possible cause of human immunodeficiency virus enteropathy.

F Clayton1, D P Kotler, S K Kuwada, T Morgan, C Stepan, J Kuang, J Le, J Fantini.   

Abstract

Human immunodeficiency virus (HIV)-infected patients often develop malabsorption and increased intestinal permeability with diarrhea, called HIV enteropathy, even without enteric opportunistic infections. HIV gp120-induced calcium signaling, microtubule loss, and physiological changes resembling HIV enteropathy were previously found in the HT-29 intestinal cell line. How gp120 caused these changes was unclear. We show that the HIV co-receptor Bob/GPR15, unlike CCR5 and CXCR4, is abundant at the basal surface of small intestinal epithelium. The gp120-induced effects on HT-29 cells were inhibited by anti-Bob neutralizing antibodies, the selective G protein inhibitor pertussis toxin, and the phospholipase inhibitor U73122, but not neutralizing antibodies to CXCR4. Gp120 strains that induced signaling in HT-29 cells also induced calcium fluxes in Bob-transfected Ghost (3) cells, whereas gp120 strains not activating HT-29 cells also did not activate Bob-transfected cells. Bob is the first HIV co-receptor shown to be abundantly expressed on the basolateral surface of intestinal epithelium. Although Bob is an inefficient infection-inducing co-receptor, it mediates viral strain-specific gp120-induced calcium signaling at low, physiologically reasonable gp120 concentrations, up to 10,000-fold lower gp120 concentrations than the principal co-receptors. Gp120-induced Bob activation is a plausible cause of HIV enteropathy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11696454      PMCID: PMC1867054          DOI: 10.1016/S0002-9440(10)63040-4

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  33 in total

1.  Effect of combination antiretroviral therapy upon rectal mucosal HIV RNA burden and mononuclear cell apoptosis.

Authors:  D P Kotler; T Shimada; G Snow; G Winson; W Chen; M Zhao; Y Inada; F Clayton
Journal:  AIDS       Date:  1998-04-16       Impact factor: 4.177

2.  Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor.

Authors:  D Weissman; R L Rabin; J Arthos; A Rubbert; M Dybul; R Swofford; S Venkatesan; J M Farber; A S Fauci
Journal:  Nature       Date:  1997-10-30       Impact factor: 49.962

3.  Expression cloning of new receptors used by simian and human immunodeficiency viruses.

Authors:  H K Deng; D Unutmaz; V N KewalRamani; D R Littman
Journal:  Nature       Date:  1997-07-17       Impact factor: 49.962

4.  Actin-dependent receptor colocalization required for human immunodeficiency virus entry into host cells.

Authors:  S Iyengar; J E Hildreth; D H Schwartz
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

5.  Duodenal biopsies of HIV-infected patients with diarrhoea exhibit epithelial barrier defects but no active secretion.

Authors:  M Stockmann; M Fromm; H Schmitz; W Schmidt; E O Riecken; J D Schulzke
Journal:  AIDS       Date:  1998-01-01       Impact factor: 4.177

6.  Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins.

Authors:  A L Edinger; T L Hoffman; M Sharron; B Lee; B O'Dowd; R W Doms
Journal:  Virology       Date:  1998-09-30       Impact factor: 3.616

7.  Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4.

Authors:  G Herbein; U Mahlknecht; F Batliwalla; P Gregersen; T Pappas; J Butler; W A O'Brien; E Verdin
Journal:  Nature       Date:  1998-09-10       Impact factor: 49.962

8.  Adaptation to promiscuous usage of CC and CXC-chemokine coreceptors in vivo correlates with HIV-1 disease progression.

Authors:  L Xiao; D L Rudolph; S M Owen; T J Spira; R B Lal
Journal:  AIDS       Date:  1998-09-10       Impact factor: 4.177

9.  Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1.

Authors:  L Zhang; T He; Y Huang; Z Chen; Y Guo; S Wu; K J Kunstman; R C Brown; J P Phair; A U Neumann; D D Ho; S M Wolinsky
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

10.  Human spiral artery renin-angiotensin system.

Authors:  T Morgan; C Craven; K Ward
Journal:  Hypertension       Date:  1998-10       Impact factor: 10.190

View more
  26 in total

Review 1.  HIV1 and the gut in the era of highly active antiretroviral therapy.

Authors:  Esteban C Nannini; Pablo C Okhuysen
Journal:  Curr Gastroenterol Rep       Date:  2002-10

2.  Phosphorylation-dependent C-terminal binding of 14-3-3 proteins promotes cell surface expression of HIV co-receptor GPR15.

Authors:  Yukari Okamoto; Sojin Shikano
Journal:  J Biol Chem       Date:  2010-12-28       Impact factor: 5.157

3.  Primary infection by a human immunodeficiency virus with atypical coreceptor tropism.

Authors:  Chunlai Jiang; Nicholas F Parrish; Craig B Wilen; Hui Li; Yue Chen; Jeffrey W Pavlicek; Anna Berg; Xiaozhi Lu; Hongshuo Song; John C Tilton; Jennifer M Pfaff; Elizabeth A Henning; Julie M Decker; M Anthony Moody; Mark S Drinker; Robert Schutte; Stephanie Freel; Georgia D Tomaras; Rebecca Nedellec; Donald E Mosier; Barton F Haynes; George M Shaw; Beatrice H Hahn; Robert W Doms; Feng Gao
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

4.  Claudin-2 as a mediator of leaky gut barrier during intestinal inflammation.

Authors:  J Luettig; R Rosenthal; C Barmeyer; J D Schulzke
Journal:  Tissue Barriers       Date:  2015-04-03

5.  HIV enteropathy: undescribed ultrastructural changes of duodenal mucosa and their regression after triple antiviral therapy. A case report.

Authors:  Brandi Giovanni; Carlo Calabrese; Roberto Manfredi; Anna Maria Pisi; Giulio Di Febo; Rossella Hakim; Giovanna Cenacchi; Guido Biasco
Journal:  Dig Dis Sci       Date:  2005-04       Impact factor: 3.199

Review 6.  Activation of GPR15 and its involvement in the biological effects of smoking.

Authors:  Sulev Kõks; Gea Kõks
Journal:  Exp Biol Med (Maywood)       Date:  2017-04-19

7.  Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals.

Authors:  Maud Mavigner; Michelle Cazabat; Martine Dubois; Fatima-Ezzahra L'Faqihi; Mary Requena; Christophe Pasquier; Pascale Klopp; Jacques Amar; Laurent Alric; Karl Barange; Jean-Pierre Vinel; Bruno Marchou; Patrice Massip; Jacques Izopet; Pierre Delobel
Journal:  J Clin Invest       Date:  2011-12-12       Impact factor: 14.808

8.  HIV-2 infection is associated with preserved GALT homeostasis and epithelial integrity despite ongoing mucosal viral replication.

Authors:  S M Fernandes; A R Pires; P Matoso; C Ferreira; H Nunes-Cabaço; L Correia; E Valadas; J Poças; P Pacheco; H Veiga-Fernandes; R B Foxall; A E Sousa
Journal:  Mucosal Immunol       Date:  2017-05-17       Impact factor: 7.313

Review 9.  HIV infection and the gastrointestinal immune system.

Authors:  J M Brenchley; D C Douek
Journal:  Mucosal Immunol       Date:  2008-01       Impact factor: 7.313

10.  The mucosal barrier and immune activation in HIV pathogenesis.

Authors:  Jason M Brenchley; Daniel C Douek
Journal:  Curr Opin HIV AIDS       Date:  2008-05       Impact factor: 4.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.